Reaction
Urinary Tract Inflammation reporting signals
As of the last recalculation, Urinary Tract Inflammation appears in 353 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is OSELTAMIVIR (PRR 92.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Oseltamivir | 12 | 92.0 | 92.1 |
| Pyrazinamide | 14 | 91.5 | 91.6 |
| Ganciclovir | 13 | 77.7 | 77.8 |
| Ganciclovir Sodium | 13 | 75.2 | 75.3 |
| Efavirenz | 13 | 71.3 | 71.4 |
| Darunavir | 14 | 56.8 | 56.8 |
| Rifampin | 13 | 54.5 | 54.5 |
| Ritonavir 100 Mg | 13 | 53.2 | 53.3 |
| Isoniazid | 14 | 53.0 | 53.1 |
| Raltegravir | 12 | 44.3 | 44.4 |
| Voriconazole Injection | 13 | 36.6 | 36.6 |
| Oseltamivir Phosphate | 13 | 32.5 | 32.6 |
| Siponimod | 3 | 20.0 | 20.0 |
| Emtricitabine And Tenofovir Disoproxil Fumarate | 13 | 17.4 | 17.4 |